IBDEI0SD ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13053,1,3,0)
 ;;=3^Conjunctivitis,Acute,Bilateral,Unspec
 ;;^UTILITY(U,$J,358.3,13053,1,4,0)
 ;;=4^H10.33
 ;;^UTILITY(U,$J,358.3,13053,2)
 ;;=^5004680
 ;;^UTILITY(U,$J,358.3,13054,0)
 ;;=H18.003^^80^753^50
 ;;^UTILITY(U,$J,358.3,13054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13054,1,3,0)
 ;;=3^Corneal Desposit,Bilateral,Unspec
 ;;^UTILITY(U,$J,358.3,13054,1,4,0)
 ;;=4^H18.003
 ;;^UTILITY(U,$J,358.3,13054,2)
 ;;=^5005006
 ;;^UTILITY(U,$J,358.3,13055,0)
 ;;=H16.403^^80^753^52
 ;;^UTILITY(U,$J,358.3,13055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13055,1,3,0)
 ;;=3^Corneal Neovascularization,Bilateral,Unspec
 ;;^UTILITY(U,$J,358.3,13055,1,4,0)
 ;;=4^H16.403
 ;;^UTILITY(U,$J,358.3,13055,2)
 ;;=^5004967
 ;;^UTILITY(U,$J,358.3,13056,0)
 ;;=H15.103^^80^753^62
 ;;^UTILITY(U,$J,358.3,13056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13056,1,3,0)
 ;;=3^Episcleritis,Bilateral,Unspec
 ;;^UTILITY(U,$J,358.3,13056,1,4,0)
 ;;=4^H15.103
 ;;^UTILITY(U,$J,358.3,13056,2)
 ;;=^5004837
 ;;^UTILITY(U,$J,358.3,13057,0)
 ;;=H16.213^^80^753^65
 ;;^UTILITY(U,$J,358.3,13057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13057,1,3,0)
 ;;=3^Exposure Keratoconjunctivitis,Bilateral
 ;;^UTILITY(U,$J,358.3,13057,1,4,0)
 ;;=4^H16.213
 ;;^UTILITY(U,$J,358.3,13057,2)
 ;;=^5004922
 ;;^UTILITY(U,$J,358.3,13058,0)
 ;;=H16.123^^80^753^73
 ;;^UTILITY(U,$J,358.3,13058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13058,1,3,0)
 ;;=3^Filamentary Keratitis,Bilateral
 ;;^UTILITY(U,$J,358.3,13058,1,4,0)
 ;;=4^H16.123
 ;;^UTILITY(U,$J,358.3,13058,2)
 ;;=^5004907
 ;;^UTILITY(U,$J,358.3,13059,0)
 ;;=H10.413^^80^753^77
 ;;^UTILITY(U,$J,358.3,13059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13059,1,3,0)
 ;;=3^Giant Papillary Conjunctivitis,Bilateral,Chronic
 ;;^UTILITY(U,$J,358.3,13059,1,4,0)
 ;;=4^H10.413
 ;;^UTILITY(U,$J,358.3,13059,2)
 ;;=^5004686
 ;;^UTILITY(U,$J,358.3,13060,0)
 ;;=H21.03^^80^753^83
 ;;^UTILITY(U,$J,358.3,13060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13060,1,3,0)
 ;;=3^Hyphema,Bilateral
 ;;^UTILITY(U,$J,358.3,13060,1,4,0)
 ;;=4^H21.03
 ;;^UTILITY(U,$J,358.3,13060,2)
 ;;=^5005174
 ;;^UTILITY(U,$J,358.3,13061,0)
 ;;=H20.053^^80^753^86
 ;;^UTILITY(U,$J,358.3,13061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13061,1,3,0)
 ;;=3^Hypopyon,Bilateral
 ;;^UTILITY(U,$J,358.3,13061,1,4,0)
 ;;=4^H20.053
 ;;^UTILITY(U,$J,358.3,13061,2)
 ;;=^5005152
 ;;^UTILITY(U,$J,358.3,13062,0)
 ;;=H21.263^^80^753^92
 ;;^UTILITY(U,$J,358.3,13062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13062,1,3,0)
 ;;=3^Iris Atrophy,Bilateral
 ;;^UTILITY(U,$J,358.3,13062,1,4,0)
 ;;=4^H21.263
 ;;^UTILITY(U,$J,358.3,13062,2)
 ;;=^5005201
 ;;^UTILITY(U,$J,358.3,13063,0)
 ;;=H16.293^^80^753^98
 ;;^UTILITY(U,$J,358.3,13063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13063,1,3,0)
 ;;=3^Keratoconjunctivitis,Bilateral NEC
 ;;^UTILITY(U,$J,358.3,13063,1,4,0)
 ;;=4^H16.293
 ;;^UTILITY(U,$J,358.3,13063,2)
 ;;=^5004945
 ;;^UTILITY(U,$J,358.3,13064,0)
 ;;=H16.203^^80^753^99
 ;;^UTILITY(U,$J,358.3,13064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13064,1,3,0)
 ;;=3^Keratoconjunctivitis,Bilateral,Unspec
 ;;^UTILITY(U,$J,358.3,13064,1,4,0)
 ;;=4^H16.203
 ;;^UTILITY(U,$J,358.3,13064,2)
 ;;=^5004919
 ;;^UTILITY(U,$J,358.3,13065,0)
 ;;=H18.603^^80^753^104
 ;;^UTILITY(U,$J,358.3,13065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13065,1,3,0)
 ;;=3^Keratoconus,Bilateral,Unspec
 ;;^UTILITY(U,$J,358.3,13065,1,4,0)
 ;;=4^H18.603
 ;;^UTILITY(U,$J,358.3,13065,2)
 ;;=^5005091
 ;;^UTILITY(U,$J,358.3,13066,0)
 ;;=H16.043^^80^753^115
